enGene Holdings is trading up 9.15% at $1.67 in pre-market on October 30, 2026, as the reason for the move remains unclear.
- No new company-specific announcement dated October 30 clearly explains the rise; the latest listed press release is from October 13.
- The Nasdaq Composite is down 2.19%, so broader market trading is moving opposite to enGeneβs gain.